Amid reports that CVS Health (CVS) is in discussions to purchase health insurance giant Aetna (AET) for $66 billion, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks regulators would approve such a deal. 

"It's pro consumer so I think they would," Cramer said. "It's very different from a Walgreens Boots Alliance (WBA) - Rite Aid (RAD) ."

Watch More with TheStreet:

Don't miss the best videos of the week. Put Wall Street on Rewind and sign up for our weekly newsletter.

More from Video

If You Want to Invest in Artificial Intelligence, Here's the One Stock to Buy

If You Want to Invest in Artificial Intelligence, Here's the One Stock to Buy

Economist Perspective: Brexit Endgame in Sight?

Economist Perspective: Brexit Endgame in Sight?

Smaller Cap Stocks Could Make Great Stocking Stuffers Ahead of 2019

Smaller Cap Stocks Could Make Great Stocking Stuffers Ahead of 2019

5 Highly Anticipated Tech IPOs to Watch in 2019

5 Highly Anticipated Tech IPOs to Watch in 2019

Trading Strategies: How to Play the Federal Reserve's Decision Next Week

Trading Strategies: How to Play the Federal Reserve's Decision Next Week